Gene expression profiling in association with interferon-alpha-sensitivity for the personalized treatment of renal cell carcinoma
肾细胞癌个体化治疗中与干扰素-α敏感性相关的基因表达谱分析
基本信息
- 批准号:15591669
- 负责人:
- 金额:$ 2.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Background. We analyzed the correlation between interferon-α (IFNα) response and gene expression profiles to predict IFNα sensitivity and identified key molecules regulating the IFNα response in renal cell carcinoma (RCC).Methods. To evaluate patients with RCC according to IFNα-response, gene expression profiling was done using 3,840 clones microarray, and then IFNα-responder related genes were selected by clustering analysis. Basically, IFNα-response of RCC cell lines was evaluated by MTT assay with 300 to 10,000 IU/ml of IFNα treatment. Microarray, followed by supervised hierarchical clustering analysis, was applied to selected genes according to IFNα sensitivity. In order to find alteration of expression profiles induced by IFNα, sequential microarray analyses were performed at 3,6, and 12 hrs after IFNα treatment of RCC cell lines and mRNA expression level was confirmed using quantitative RT-PCR. A model for prediction of IFNα response was created according to the statistical correlation between gene expression profiles and IFNα-sensitivity.Results. According to microarray analysis in 14 patients with RCC,IFNα-responder might be identified by the selected gene sets. Microarray followed clustering analysis between IFNα-sensitive and IFNα-resistant line, seven genes, ADFP,MITF,MTUS1,PME-1,MLLT3,MLF1, and TNNT1, were eventually selected as candidates for IFNα-sensitivity-related genes in RCC cell lines. We further developed a model to predict tumor-inhibition with four molecules, i.e., ADFP,MITF,MTUS1, and TNNT1, using multiple linear regression analysis (coefficient=0.948,p=0.0291) and validated the model using primary cultured RCC cells.Conclusions. The expression levels of the combined selected genes can provide predictive information on the IFNα response in RCC. Furthermore, the IFNα-response to RCC might be modulated by regulation of the expression level of these molecules.
背景我们分析了干扰素-α(IFNα)反应与基因表达谱之间的相关性,以预测IFNα敏感性,并确定了调节肾癌(RCC)IFNα反应的关键分子。为了根据IFNα应答评估RCC患者,使用3,840个克隆的基因表达谱芯片进行基因表达谱分析,然后通过聚类分析选择IFNα应答相关基因。基本上,RCC细胞系的IFNα应答通过MTT测定用300至10,000 IU/ml的IFNα处理来评价。微阵列,然后监督分层聚类分析,应用于选定的基因,根据IFNα的敏感性。为了观察IFNα对肾癌细胞基因表达谱的影响,采用基因芯片技术,在IFNα处理肾癌细胞3、6、12 h后,用定量RT-PCR检测mRNA表达水平。根据基因表达谱与IFNα敏感性之间的统计学相关性,建立了IFNα应答预测模型。根据14例肾细胞癌患者的基因芯片分析,选择的基因集可能是确定IFNα应答者的依据。通过基因芯片对IFNα敏感株和IFNα耐药株进行聚类分析,最终筛选出ADFP、MITF、MTUS 1、PME-1、MLLT 3、MLF 1和TNNT 1 7个基因作为肾癌细胞IFNα敏感相关基因的候选基因。我们进一步开发了一个模型来预测四种分子的肿瘤抑制作用,即,ADFP、MITF、MTUS 1和TNNT 1的表达水平进行多元线性回归分析(相关系数= 0.948,p =0.0291),并以原代培养的肾细胞癌细胞为模型进行验证。联合选择的基因的表达水平可以提供关于RCC中IFNα应答的预测信息。此外,IFNα对RCC的反应可能通过调节这些分子的表达水平来调节。
项目成果
期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Gene Expression Profiling Identifies Platelet-Derived Growth Factor as a Diagnostic Molecular Marker for Papillary Thyroid Carcinoma
- DOI:10.1158/1078-0432.ccr-0807-03
- 发表时间:2004-03
- 期刊:
- 影响因子:11.5
- 作者:Yukiko Yano;N. Uematsu;T. Yashiro;H. Hara;E. Ueno;M. Miwa;G. Tsujimoto;Y. Aiyoshi;K. Uchida
- 通讯作者:Yukiko Yano;N. Uematsu;T. Yashiro;H. Hara;E. Ueno;M. Miwa;G. Tsujimoto;Y. Aiyoshi;K. Uchida
鳥居 徹, 他: "進行腎癌に対するインターフェロンα治療テーラーメイド化のための基礎的検討"癌の臨床. 50. 7-13 (2004)
Toru Torii 等人:“针对晚期肾癌定制干扰素 α 治疗的基础研究”癌症临床研究 50. 7-13 (2004)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Differential profiling analysis of proteins involved in anti-proliferative effect of interferon-alpha on renal cell carcinoma cell lines by protein biochip technology
利用蛋白质生物芯片技术对干扰素-α对肾细胞癌细胞系的抗增殖作用相关蛋白质进行差异分析
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Nakamura K;Shimazui;T;et al.
- 通讯作者:et al.
Rapid inhibition of MAPK signaling and anti-proliferation effect via JAK/STAT signaling by interferon-alpha in hepatocellular carcinoma cell lines.
干扰素-α 在肝细胞癌细胞系中快速抑制 MAPK 信号传导并通过 JAK/STAT 信号传导发挥抗增殖作用。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Honda A et al.;Honda A et al.;Honda A et al.;Honda A et al.;Honda A et al.;Honda A et al.;Matsuzaki Y et al.;Hirayama T et al.;Matsuzaki Y et al.;Matsuzaki Y et al.;Hirayama T et al.;Zhang Y et al.;Jiang Y et al.;Inamura K et al.
- 通讯作者:Inamura K et al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHIMAZUI Toru其他文献
SHIMAZUI Toru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHIMAZUI Toru', 18)}}的其他基金
New strategy of intravesical in stillation using anti-cancer peptide for bladder tumor
抗癌肽膀胱灌注治疗膀胱肿瘤新策略
- 批准号:
21592031 - 财政年份:2009
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Prediction of in vitro response to interferon-alpha and acquisition of its susceptibility by gene and peptide transduction system
通过基因和肽转导系统预测干扰素-α的体外反应并获取其敏感性
- 批准号:
18591739 - 财政年份:2006
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Alteration of expression profiling related the biological characteristics of renal cell carcinoma using cDNA microarray.
使用 cDNA 微阵列表达谱的改变与肾细胞癌的生物学特征相关。
- 批准号:
13671633 - 财政年份:2001
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Expression and prognostic significance of cadherin and detection system of ciculating cancer cells in renal cell carcinoma
肾细胞癌中钙粘蛋白的表达及预后意义及循环癌细胞检测系统
- 批准号:
10671457 - 财政年份:1998
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Beta Cell Heterogeneity in the Interferon Alpha Response
干扰素α反应中的β细胞异质性
- 批准号:
10751684 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Vascular changes are a key contributor to and novel drug target for interferon-alpha induced neurological disease
血管变化是干扰素α诱导的神经系统疾病的关键因素和新的药物靶点
- 批准号:
nhmrc : 2001543 - 财政年份:2021
- 资助金额:
$ 2.24万 - 项目类别:
Ideas Grants
Elucidation of the mechanism of interferon alpha overproduction in systemic lupus erythematosus
系统性红斑狼疮中干扰素α过量产生的机制的阐明
- 批准号:
20K17452 - 财政年份:2020
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effect of interferon alpha subtypes on NK cell-mediated effector functions.
干扰素 α 亚型对 NK 细胞介导的效应功能的影响。
- 批准号:
551483-2020 - 财政年份:2020
- 资助金额:
$ 2.24万 - 项目类别:
University Undergraduate Student Research Awards
Functional and molecular characterization of the human islet interferon alpha response
人胰岛干扰素α反应的功能和分子特征
- 批准号:
10264921 - 财政年份:2020
- 资助金额:
$ 2.24万 - 项目类别:
Regulation of transforming growth factor is involved in the efficacy of combined 5-fluorouracil and interferon alpha-2b therapy of advanced hepatocellular carcinoma
转化生长因子的调节参与5-氟尿嘧啶和干扰素α-2b联合治疗晚期肝细胞癌的疗效
- 批准号:
15K09020 - 财政年份:2015
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanisms of autoimmune thyroid disease and the role of interferon-alpha
自身免疫性甲状腺疾病的机制和干扰素-α的作用
- 批准号:
8699376 - 财政年份:2014
- 资助金额:
$ 2.24万 - 项目类别:
Interferon Alpha as a Tool for Gene Discovery in Human Lupus
干扰素α作为人类狼疮基因发现的工具
- 批准号:
8926536 - 财政年份:2014
- 资助金额:
$ 2.24万 - 项目类别:
Mechanisms of autoimmune thyroid disease and the role of interferon-alpha
自身免疫性甲状腺疾病的机制和干扰素-α的作用
- 批准号:
8880197 - 财政年份:2014
- 资助金额:
$ 2.24万 - 项目类别:
Mechanisms of autoimmune thyroid disease and the role of interferon-alpha
自身免疫性甲状腺疾病的机制和干扰素-α的作用
- 批准号:
9262903 - 财政年份:2014
- 资助金额:
$ 2.24万 - 项目类别: